BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells

Osteosarcoma (OS) survival rates have plateaued in part due to a lack of new therapeutic options. Here we demonstrate that bromodomain inhibitors (BETi), JQ1, I-BET151, I-BET762, exert potent anti-tumour activity against primary and established OS cell lines, mediated by inhibition of BRD4. Striking...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Emma K, Taylor, Scott, Gupte, Ankita, Sharp, Phillip P, Walia, Mannu, Walsh, Nicole C, Zannettino, Andrew CW, Chalk, Alistair M, Burns, Christopher J, Walkley, Carl R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421868/
https://www.ncbi.nlm.nih.gov/pubmed/25944566
http://dx.doi.org/10.1038/srep10120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421868/
https://www.ncbi.nlm.nih.gov/pubmed/25944566
http://dx.doi.org/10.1038/srep10120

Ejemplares similares